Analysis of Multiple Growth Regulatory Proteins Using Dissociable Staining Antibody Arrays on Solid Tumor Biopsy Specimens

REFERENCES

• Park CC, Bissell MJ, Barcellos-Hoff MH. The influence of the microenvironment on the malignant phenotype. Molecular Medicine Today 6:324–329, 2000.
   PubMedGoogle Scholar
• Tlsty TD, Hein PW. Know thy neighbor: stromal cells can contribute oncogenic signals. Current Opinion in Genetics and Development 11;54–59, 2001.
   PubMed Web of Science ®Google Scholar
• Barcellos-Hoff MH, Ravani SA. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Research 60:1254–1260, 2000.
   PubMed Web of Science ®Google Scholar
• Ohuchida K, Mizumoto K, Murakami M, Qian LW, Sato N, Nagai E, Matsumoto K, Nakamura T, Tanaka M. Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions. Cancer Research 64:3215–3222, 2004.
   PubMed Web of Science ®Google Scholar
• Bhowmick NA, Moses HL. Tumour stroma interactions. Current Opinion in Genetics and Development 15(1):97, 2005.
   PubMed Web of Science ®Google Scholar
• Morrison DJ, English MA, Licht JD. WT1 induces apoptosis through transcriptional regulation of the proapoptotic Bcl-2 family member Bak. Cancer Research 65(18):8174–8182, 2005.
   PubMedGoogle Scholar
• Lee SB, Haber DA. Wilms tumor and the WT1 gene. Experimental Cell Research 264(1):74–99, 2001.
   PubMedGoogle Scholar
• Koesters R, Ridder R, Kopp-Schneider A, Betts D, Adams V, Niggli F, Briner J, Von Knebel Doeberitz M. Mutational activation of the beta-catenin proto-oncogene is a common event in the development of Wilms’ tumors. Cancer Research 59(16):3880–3882, 1999.
   PubMed Web of Science ®Google Scholar
• Bardeesy N, Falkoff D, Petruzzi MJ, Nowak N, Zabel B, Adam M, Aguiar MC, Grundy P, Shows T, Pelletier J. Anaplastic Wilms' tumor, a subtype displaying poor prognosis, harbours p53 gene mutations. Nature Genetics 7(1):91–97, 1994.
   PubMedGoogle Scholar
• Quackenbush J. Microarray analysis and tumor classification. New England Journal of Medicine 354(23):2463–2472, 2006.
   PubMedGoogle Scholar
• Schramm A, Schulte JH, Klein-Hitpass L, Havers W, Sieverts H, Berwanger B, Christiansen H, Warnat P, Brors B, Eils J, Eils R, Eggert A. Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling. Oncogene 24(53):7902–7912, 2005.
   PubMedGoogle Scholar
• Armstrong SA, Golub TR, Korsmeyer SJ. MLL-rearranged leukemias: Insights from the gene expression profiling. Seminars in Hematology 40:268–273, 2003.
   PubMedGoogle Scholar
• Knezevic V, Leethanakul C, Bichsel VE, Worth JM, Prabhu VV, Gutkind JS, Liotta LA, Munson PJ, Petricoin III, EF, Krizman DB. Proteomic profiling of the cancer microenvironment by antibody arrays. Proteomics 1:1271–1278, 2001.
   PubMed Web of Science ®Google Scholar
• Nishizuka S. Profiling cancer stem cells using protein array technology. European Journal of Cancer 42(9):1273–1282, 2006.
   PubMedGoogle Scholar
• Chen CS, Zhu H. Protein microarrays. Biotechniques 40(4):423, 425, 427, 2006.
   Google Scholar
• Gulmann C, Sheehan KM, Kay EW, Liotta LA, Petricoin III EF. Array-based proteomics: mapping of protein circuitries for diagnostics, prognostics, and therapy guidance in cancer. Journal of Pathology 208(5):595–606, 2006.
   PubMedGoogle Scholar
• Haab BB. Methods and applications of antibody microarrays in cancer research. Proteomics 3(11):2116–2122, 2003.
   PubMed Web of Science ®Google Scholar
• Wang Y. Immunostaining with dissociable antibody microarrays. Proteomics 4(1):20–26, 2004.
   PubMedGoogle Scholar
• Hwang H, Quenneville L, Yaziji H, Gown AM. Wilms tumor gene product: sensitive and contextually specific marker of serous carcinomas of ovarian surface epithelial origin. Applied Immunohistochemistry & Molecular Morphology 12(2):122–126, 2004.
   Google Scholar
• Richter T, Nahrig J, Komminoth P, Kowolik J, Werner M. Protocol for ultrarapid immunostaining of frozen sections. Journal of Clinical Pathology 52(6):461–463, 1999.
   PubMedGoogle Scholar
• Rigolet M, Faussillon M, Baudry D, Junien C, Jeanpierre C. Profiling of differential gene expression in Wilms tumor by cDNA expression array. Pediatric Nephrology 16(12):1113–1121, 2001.
   PubMed Web of Science ®Google Scholar
• Dejong V, Degeorges A, Filleur S, Ait-Si-Ali S, Mettouchi A, Bornstein P, Binetruy B, Cabon F. The Wilms’ tumor gene product represses the transcription of thrombospondin 1 in response to overexpression of c-Jun. Oncogene 18(20):3143–3151, 1999.
   PubMedGoogle Scholar